Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study
Table 5
Outcomes of patients by platelet refractory status based on the platelet increment (<10000 × 106/L) definition.
Total (N = 259)
Yes (N = 142)
No (N = 117)
value
ICU mortality
N (%)
153 (59.1)
86 (60.6)
67 (57.3)
0.55
Hospital mortality
N (%)
189 (73.0)
105 (73.9)
84 (71.8)
0.70
New tracheostomy/238 patients∗
N (%)
25 (10.9)
19 (14.4)
6 (6.1)
0.046
Duration of mechanical ventilation (days)/238 patients∗
Median (Q1, Q3)
10.0 (6.0, 17.0)
10.0 (5.0, 15.8)
12.0 (6.0, 19.5)
0.15
ICU length of stay (days)
Median (Q1, Q3)
13.0 (7.0, 23.0)
16.0 (8.0, 26.0)
12.0 (6.0, 21.0)
0.02
Hospital length of stay (days)
Median (Q1, Q3)
28.0 (16.0, 58.0)
33.0 (16.0, 62.5)
27.0 (14.0, 47.0)
0.11
∗For patients with missing data, the denominator is the number of patients with valid observations. For the calculation of percentages, only valid observations are used in the numerator and denominator. ICU: intensive care unit, Q1: first quartile, Q3: third quartile.
